# Quoin Pharmaceuticals Ltd.: filings

QNRX · Nasdaq · CIK 1671502 · [Healthcare](/sectors/healthcare.md)

Pages: [Overview](/companies/qnrx.md) · [Financials](/companies/qnrx/financials.md) · [Filings](/companies/qnrx/filings.md) · [Insiders](/companies/qnrx/insiders.md)

## Reports and events: 281 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 176, 8-K 64, 4 51, 424B3 48, CORRESP 21, EFFECT 20, UPLOAD 14, SC 13G 13, 10-Q 11, 3 10, SC 13G/A 10, F-1/A 9, SCHEDULE 13G 9, SCHEDULE 13G/A 9, POS AM 8, S-8 7, 20-F 6, 424B4 6, DEF 14A 6, PRE 14A 6, D 5, F-1 5, 10-K 4, 3/A 4, ARS 4, 424B5 3, F-4/A 3, S-1 3, S-1/A 3, 4/A 2, 6-K/A 2, DEFA14A 2, DRS/A 2, DRSLTR 2, F-3 2, RW 2, S-3 2, SC 13D/A 2, SCHEDULE 13D 2, SCHEDULE 13D/A 2, 144 1, 20-F/A 1, 25-NSE 1, 8-A12B 1, 8-K/A 1, CERTNAS 1, DRS 1, F-1MEF 1, F-4 1, F-6 1, FWP 1, POS EX 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 06:35 ET | [8-K](/filings/0001104659-26-117080.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-117080 |
| 2026-10-14 | 06:35 ET | [8-K](/filings/0001104659-26-115709.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-115709 |
| 2026-10-02 | 16:42 ET | [DEF 14A](/filings/0001104659-26-113301.md) | Proxy statement, period 2026-11-12 | 0001104659-26-113301 |
| 2026-09-22 | 16:15 ET | [8-K](/filings/0001104659-26-109639.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-109639 |
| 2026-09-10 | 16:05 ET | [8-K](/filings/0001104659-26-106705.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-106705 |
| 2026-08-28 | 10:31 ET | [8-K](/filings/0001104659-26-102917.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-102917 |
| 2026-08-20 | 16:19 ET | [8-K](/filings/0001104659-26-099239.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events | 0001104659-26-099239 |
| 2026-08-14 | 16:06 ET | [8-K](/filings/0001104659-26-097094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-097094 |
| 2026-08-14 | 16:02 ET | [10-Q](/filings/0001104659-26-097064.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097064 |
| 2026-07-16 | 07:30 ET | [DEF 14A](/filings/0001104659-26-084078.md) | Proxy statement, period 2026-08-20 | 0001104659-26-084078 |
| 2026-06-23 | 16:15 ET | [8-K](/filings/0001104659-26-076822.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-076822 |
| 2026-06-04 | 16:04 ET | [8-K](/filings/0001104659-26-070501.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-070501 |
| 2026-05-07 | 16:13 ET | [8-K](/filings/0001104659-26-057140.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-057140 |
| 2026-05-07 | 13:34 ET | [10-Q](/filings/0001104659-26-056941.md) | Quarterly report, period 2026-03-31 | 0001104659-26-056941 |
| 2026-03-26 | 16:38 ET | [10-K](/filings/0001104659-26-035251.md) | Annual report, period 2025-12-31 | 0001104659-26-035251 |
| 2026-03-26 | 09:35 ET | [8-K](/filings/0001104659-26-034951.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-034951 |
| 2026-03-11 | 16:30 ET | [8-K](/filings/0001104659-26-026410.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-026410 |
| 2026-01-20 | 17:18 ET | [8-K](/filings/0001104659-26-005127.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-005127 |
| 2025-11-17 | 17:00 ET | [8-K](/filings/0001104659-25-113237.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-113237 |
| 2025-11-12 | 08:00 ET | [8-K](/filings/0001104659-25-109802.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-109802 |
| 2025-11-06 | 16:30 ET | [10-Q](/filings/0001104659-25-107785.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107785 |
| 2025-11-06 | 16:18 ET | [8-K](/filings/0001104659-25-107747.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-107747 |
| 2025-10-21 | 16:40 ET | [8-K](/filings/0001104659-25-101269.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-101269 |
| 2025-10-15 | 16:15 ET | [8-K](/filings/0001104659-25-099735.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-099735 |
| 2025-08-27 | 06:06 ET | [8-K](/filings/0001104659-25-083248.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-083248 |
| 2025-08-21 | 17:28 ET | [8-K](/filings/0001104659-25-081480.md) | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-081480 |
| 2025-08-07 | 16:58 ET | [10-Q](/filings/0001410578-25-001613.md) | Quarterly report, period 2025-06-30 | 0001410578-25-001613 |
| 2025-08-07 | 16:57 ET | [8-K](/filings/0001104659-25-075244.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-075244 |
| 2025-07-17 | 16:01 ET | [DEF 14A](/filings/0001104659-25-068650.md) | Proxy statement, period 2025-08-21 | 0001104659-25-068650 |
| 2025-07-08 | 17:07 ET | [8-K](/filings/0001104659-25-066451.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-066451 |
| 2025-06-25 | 08:56 ET | [8-K](/filings/0001104659-25-062406.md) | 8.01 Other events | 0001104659-25-062406 |
| 2025-06-20 | 16:30 ET | [8-K](/filings/0001104659-25-061184.md) | 8.01 Other events | 0001104659-25-061184 |
| 2025-06-04 | 16:00 ET | [8-K](/filings/0001104659-25-056378.md) | 5.02 Departure or appointment of officers or directors | 0001104659-25-056378 |
| 2025-05-23 | 17:33 ET | [8-K](/filings/0001104659-25-052062.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-052062 |
| 2025-05-21 | 08:31 ET | [8-K](/filings/0001104659-25-051324.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-051324 |
| 2025-05-14 | 16:49 ET | [8-K](/filings/0001104659-25-048579.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-048579 |
| 2025-05-13 | 16:04 ET | [10-Q](/filings/0001410578-25-001226.md) | Quarterly report, period 2025-03-31 | 0001410578-25-001226 |
| 2025-04-30 | 17:09 ET | [8-K](/filings/0001104659-25-042661.md) | 8.01 Other events | 0001104659-25-042661 |
| 2025-04-04 | 16:05 ET | [8-K](/filings/0001104659-25-032189.md) | 3.03 Change to security holders’ rights | 0001104659-25-032189 |
| 2025-04-04 | 08:30 ET | [8-K](/filings/0001104659-25-032004.md) | 3.03 Change to security holders’ rights | 0001104659-25-032004 |
| 2025-04-02 | 16:59 ET | [8-K](/filings/0001104659-25-031240.md) | 8.01 Other events | 0001104659-25-031240 |
| 2025-03-20 | 16:30 ET | [8-K](/filings/0001104659-25-026176.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-25-026176 |
| 2025-03-13 | 16:31 ET | [10-K](/filings/0001410578-25-000336.md) | Annual report, period 2024-12-31 | 0001410578-25-000336 |
| 2025-03-13 | 16:05 ET | [8-K](/filings/0001104659-25-023447.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-023447 |
| 2025-02-27 | 16:16 ET | [8-K](/filings/0001104659-25-018234.md) | 8.01 Other events | 0001104659-25-018234 |
| 2025-02-04 | 16:30 ET | [8-K](/filings/0001104659-25-009137.md) | 8.01 Other events | 0001104659-25-009137 |
| 2025-01-28 | 16:44 ET | [SCHEDULE 13D/A](/filings/0001104659-25-006734.md) | Ownership report, active investor, amended | 0001104659-25-006734 |
| 2025-01-28 | 16:43 ET | [SCHEDULE 13D/A](/filings/0001104659-25-006733.md) | Ownership report, active investor, amended | 0001104659-25-006733 |
| 2025-01-23 | 16:15 ET | [8-K](/filings/0001104659-25-005619.md) | 8.01 Other events | 0001104659-25-005619 |
| 2025-01-16 | 16:30 ET | [8-K](/filings/0001104659-25-004132.md) | 8.01 Other events | 0001104659-25-004132 |

Page 1 of 6. [Older](/companies/qnrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 20:22 ET. No prices; not investment advice.